TrianglePUBLICATIONS · 23704196
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2013 Sep
- First author
- Schneeweiss A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Schneeweiss A
- type
- Author
- name
- Chia S
- type
- Author
- name
- Hickish T
- type
- Author
- name
- Harvey V
- type
- Author
- name
- Eniu A
- type
- Author
- name
- Hegg R
- type
- Author
- name
- Tausch C
- type
- Author
- name
- Seo JH
- type
- Author
- name
- Tsai YF
- type
- Author
- name
- Ratnayake J
- type
- Author
- name
- McNally V
- type
- Author
- name
- Ross G
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Schneeweiss A
- type
- Author
- name
- Chia S
- type
- Author
- name
- Hickish T
- type
- Author
- name
- Harvey V
- type
- Author
- name
- Eniu A
- type
- Author
- name
- Hegg R
- type
- Author
- name
- Tausch C
- type
- Author
- name
- Seo JH
- type
- Author
- name
- Tsai YF
- type
- Author
- name
- Ratnayake J
- type
- Author
- name
- McNally V
- type
- Author
- name
- Ross G
- type
- Author
- bibliography ids
- nci-bib-73f80020f6fae692aa9e2848
- book metadata
- content sha256
- 1c2c8211d0e91947d3e3f45b011394f41f273ae30e0d6ca472f69530ad055c89
- document type
- citation
- dois
- 10.1093/annonc/mdt182
- electronic publication date
- display
- 2013 May 22
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23704196
- immutable id
- pubmed:23704196@1c2c8211d0e91947d3e3f45b011394f41f273ae30e0d6ca472f69530ad055c89
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 9
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 2278-84
- volume
- 24
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23704196
- provenance
- batch id
- 99e008dabc339d38fd44
- provider
- NCBI PubMed ESummary
- record sha256
- 71438dfc51c62615e939cbfbcff2b625768d09c94041a2b7b9ebbf848fb19d39
- response sha256
- 804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
- retrieved at
- 2026-09-09T23:46:55.094762+00:00
- publication date
- display
- 2013 Sep
- precision
- month
- year
- 2013
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
Preserved source evidence · Not medical advice